This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Two Of The Nation's Top Specialists In Lupus, Drs. Swamy Venuturupalli & Daniel Wallace, Join In Expanding Research On Auto-Immune Diseases

BEVERLY HILLS, Calif., April 1, 2013 /PRNewswire/ -- In a new association of nationally renowned specialists on Lupus and auto-immune disorders, Dr. Swamy Venuturupalli, is joining with Dr. Daniel Wallace to accelerate research into those diseases along with their expanded clinical practice. The two noted clinician scientists will base an aggressive and well-funded study program out of "The Wallace Rheumatic Diseases Research Center" in West Hollywood, CA. Dr. Venuturupalli established a strong Lupus research and public education program over the past ten years in his group practice with Beverly Medical Associates.

(Photo: http://photos.prnewswire.com/prnh/20130401/LA85971)

"The last several decades have expanded our understanding of the genetic and molecular causes of autoimmune diseases. This information now has to be applied to the care of patients suffering from these conditions, and that will be the focus of the next decade," explains Dr. Venuturupalli.  He notes that the move coincides with his desire for growth in the areas of patient education and autoimmune disease research and widens the service of their respective infusion centers.In addition to evolving his clinical practice in the areas of lupus, autoimmune and inflammatory diseases, Dr. Venuturupalli notes that the association will continue to teach and lecture on a wide variety of health topics. Dr. Venuturupalli explains his philosophy simply, "As a physician, I believe that every case is unique, and how lupus affects one person is vastly different than how it affects another. It has been my endeavor to try and understand each individual patient and tailor my approach to their particular illness."

"Dr. Venuturupalli is an inspiration," comments Kathy Ireland CEO of kathy ireland Worldwide (kiWW) who has addressed part of her health activism to the progress of knowledge in auto-immune concerns.  "His commitment to the battle against Lupus and his leadership and knowledge in the pivotal role of managing inflammation is a pathway to better living for people everywhere." Kathy Ireland is recognized as one of the top 10 Women's Health Advocates in America. Today, kiWW confirmed plans to collaborate with Dr. Venuturupalli on making critical information available on Lupus and the role of inflammation in health and wellness.

Dr. Venutrupalli states that he finds he is able to reach only a limited number of individuals through his practice and wants to find ways to educate patients about the advances in care for lupus and related disorders. He has taken to the web in order to achieve this. He is the featured expert on the WebMD Lupus Support Group ( http://exchanges.webmd.com/lupus-exchange) and uses his website to disseminate tips on healthy living and exercise.

The move to collaborate with Dr. Wallace will allow both doctors to have access to each others' patients and provide a superior level of care for autoimmune diseases, which can sometimes be serious and life threatening. "Having collaborated with Dr. Venuturupalli on many clinical trials, this move is perfect synergy," says Dr. Wallace.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs